In the US, Astemizole (astemizole systemic) is a member of the drug class antihistamines and is used to treat Allergic Urticaria, Allergies and Urticaria.
US matches:
- Astemizole
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
R06AX11
CAS registry number (Chemical Abstracts Service)
0068844-77-9
Chemical Formula
C28-H31-F-N4-O
Molecular Weight
458
Therapeutic Categories
Antiallergic agent
Antihistaminic agent
Chemical Name
1H-Benzimidazole-2-amine, 1-[(4-fluorophenyl)methyl]-N-[1-[2-(4-methoxyphenyl)ethyl]-4-piperidinyl]-
Foreign Names
- Astemizolum (Latin)
- Astemizol (German)
- Astémizole (French)
- Astemizol (Spanish)
Generic Names
- Astemizole (OS: BAN, USAN)
- Astémizole (OS: DCF)
- R 43512 (IS)
- Astemizol (PH: Ph. Eur. 6)
- Astemizole (PH: BP 2010, USP 32, Ph. Eur. 6)
- Astémizole (PH: Ph. Eur. 6)
- Astemizolum (PH: Ph. Eur. 6)
Brand Names
- Asmoval
Remedica, Taiwan - Astemizol
Synthesis, Colombia - Astesen
Senosiain, Mexico - Histalong
Biofarma, Venezuela - Lergibrumizol
Bruluart, Mexico
International Drug Name Search
Glossary
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment